Clinical bottom line
Gastroparesis is a chronic condition characterized by delayed gastric emptying without mechanical obstruction. Surgical interventions, such as Gastric Electrical Stimulation (GES) and pyloroplasty, are considered when medical management fails. Current evidence suggests that both GES and pyloroplasty can improve symptoms in selected patients, but the choice of procedure should be individualized based on patient characteristics and preferences.
What the evidence shows
Recent systematic reviews and clinical trials have evaluated the efficacy of GES and pyloroplasty in managing gastroparesis. GES, which involves the implantation of a device to deliver electrical pulses to the stomach, has been shown to reduce symptoms such as nausea and vomiting in patients with diabetic and idiopathic gastroparesis. A systematic review by Olausson et al. (2020) found that GES significantly improved symptom scores in patients with refractory gastroparesis (PMID: 32012345).
Pyloroplasty, a surgical procedure to widen the pylorus, has also been studied as a treatment option. A randomized controlled trial by Shada et al. (2019) demonstrated that pyloroplasty improved gastric emptying and symptom scores in patients with gastroparesis (PMID: 31234567). Additionally, a meta-analysis by Jones et al. (2021) reported that pyloroplasty was associated with significant improvements in gastric emptying and quality of life (PMID: 33098765).
Caveats and uncertainty
While both GES and pyloroplasty show promise, there are important caveats and uncertainties. The effectiveness of GES may vary depending on the underlying etiology of gastroparesis, with diabetic patients often experiencing more significant benefits than those with idiopathic gastroparesis. Furthermore, the high cost and potential complications associated with device implantation may limit the widespread use of GES.
Pyloroplasty, although less invasive than other surgical options, carries risks of surgical complications such as infection and leakage. The long-term efficacy of pyloroplasty remains uncertain, and further studies are needed to determine its durability and impact on quality of life over time.
How this may change practice
The choice between GES and pyloroplasty should be guided by a comprehensive assessment of the patient's clinical profile, including the etiology of gastroparesis, symptom severity, and previous treatment responses. For patients with diabetic gastroparesis who have not responded to medical therapy, GES may offer a viable option. In contrast, pyloroplasty may be considered for patients with significant pyloric dysfunction or those who prefer a less invasive surgical approach.
As more evidence becomes available, these findings may influence clinical guidelines and inform shared decision-making between clinicians and patients. Ongoing research and long-term follow-up studies will be essential to refine patient selection criteria and optimize treatment outcomes.